AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18414100
Drug: Bilateral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilateral treatment with latanoprost
Trial: 18414100
Drug: Correlation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Correlation of fellow eyes in bilateral treatment
Trial: 18414100
Drug: Correlation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Correlation of baseline IOP at each time point between fellow eyes in one-eye trials and bilateral treatment
Trial: 16625522
Drug: etifoxine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: etifoxine (50 mg tid)
Trial: 6293834
Drug: Bacmecillinam 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bacmecillinam 100 mg
Trial: 6293834
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of Bacmecillinam 400 mg vs Pivmecillinam 400 mg
Trial: 30859975
Drug: Aripiprazole Once-Monthly
RxNorm normalized name: Aripiprazole
DrugBank: Aripiprazole (DB01238)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Aripiprazole Once-Monthly 400mg (AOM 400) administered every 4 weeks for up to 52 weeks
Trial: 30859975
Drug: Aripiprazole Once-Monthly
RxNorm normalized name: Aripiprazole
DrugBank: Aripiprazole (DB01238)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Aripiprazole Once-Monthly 400mg (AOM 400)
Trial: 24281275
Drug: Ropivacaine continuous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine continuous infusion
Trial: 18334909
Drug: Iloperidone 24
RxNorm normalized name: Iloperidone
DrugBank: Iloperidone (DB04946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iloperidone 24 mg/d
Trial: 19375893
Drug: Ziprasidone 160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ziprasidone 160 mg/d
Trial: 15704615
Drug: Esomeprazole MUPS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole MUPS 40 mg tablets without hard gelatine capsule (Reference)
Trial: 16189197
Drug: High-dose GH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose GH
Trial: 10417491
Drug: Nebuliser solution
RxNorm normalized name: Pentamidine isetionate 300 mg powder for nebuliser solution vial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebuliser solution plus isotonic saline (20 mg)
Trial: 10417491
Drug: Nebuliser solution
RxNorm normalized name: Pentamidine isetionate 300 mg powder for nebuliser solution vial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebuliser solution plus saline and procaterol (20 mg)
Trial: 8853774
Drug: Evening primrose
RxNorm normalized name: EVENING PRIMROSE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evening primrose oil (4 g daily for 12 months)
Trial: 8853774
Drug: Liquid paraffin
RxNorm normalized name: Liquid paraffin
DrugBank: Mineral oil (DB11057)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liquid paraffin capsules (placebo)
Trial: 1346877
Drug: TRH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRH treatment (4 doses of 400 micrograms 8‐hourly)
Trial: 11230588
Drug: TRH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRH treatment
Trial: 6140699
Drug: Nitrazepam 5
RxNorm normalized name: nitrazepam 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrazepam 5 mg + Placebo (Ethanol 0.1 g/kg)
Trial: 6140699
Drug: Temazepam 20
RxNorm normalized name: temazepam 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temazepam 20 mg + Placebo (Ethanol 0.1 g/kg)
Trial: 2895705
Drug: Temazepam 20
RxNorm normalized name: temazepam 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temazepam 20 mg
Trial: 27600257
Drug: Permethrin 5%
RxNorm normalized name: PERMETHRIN 5% CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Permethrin 5% topical gel
Trial: 12021827
Drug: Citicoline 500
RxNorm normalized name: citicoline 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citicoline 500 mg orally once daily for 6 weeks
Trial: 9892879
Drug: Rabeprazole 20
RxNorm normalized name: RABEprazole 20 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole 20 mg once daily for 4 or 8 weeks
Trial: 11220352
Drug: Placebo (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (50 mg of starch)
Trial: 29278278
Drug: Linaclotide 0.125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linaclotide 0.125 mg
Trial: 29278278
Drug: Linaclotide 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linaclotide 0.25 mg
Trial: 29278278
Drug: Linaclotide 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linaclotide 0.5 mg
Trial: 9026280
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose GnRH agonist
Trial: 2055292
Drug: Intravenous recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF)
Trial: 2055292
Drug: Subcutaneous recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF)
Trial: 3707649
Drug: Ibopamine 50
RxNorm normalized name: ibopamine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibopamine 50 mg
Trial: 1678273
Drug: Ibopamine 100
RxNorm normalized name: ibopamine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibopamine 100 mg
Trial: 30817764
Drug: Patterned, frequency-modulated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patterned, frequency-modulated oral stimulation via the NTrainer system through a pulsatile pacifier
Trial: 24697925
Drug: Control (intravenous/oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (intravenous/oral placebo)
Trial: 773414
Drug: Clobetasol propionate
RxNorm normalized name: Clobetasol Propionate
DrugBank: Clobetasol propionate (DB01013)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Clobetasol propionate 0.05% ointment
Trial: 11153592
Drug: auto-CPAP treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: auto-CPAP treatment
Trial: 11153592
Drug: conventional CPAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: conventional CPAP treatment
Trial: 28755782
Drug: Romosozumab (210
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Romosozumab (210 mg once monthly)
Trial: 27487526
Drug: Teriparatide (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teriparatide (20 µg once daily)
Trial: 28153659
Drug: Enoxaparin 40
RxNorm normalized name: ENOXAPARIN 40MG/0.4ML INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin 40 mg (4000 IU) by subcutaneous injection daily from recruitment until 36+0 weeks or delivery
Trial: 22784845
Drug: 400 IU
RxNorm normalized name: Vitamin D 400 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 IU vitamin D3 daily for 6 months
Trial: 22784845
Drug: 2,000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2,000 IU vitamin D3 daily for 6 months
Trial: 18979150
Drug: Tocilizumab placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocilizumab placebo plus MTX 8 mg/week
Trial: 18979150
Drug: Tocilizumab 8
RxNorm normalized name: tocilizumab 80 MG in 4 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocilizumab 8 mg/kg every 4 weeks plus MTX placebo
Trial: 2691694
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no antihypertensive treatment)
Trial: 1190102
Drug: Daily administration
RxNorm normalized name: Prevpac 30mg-500mg-500mg Daily Administration Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily administration of 2 g of vitamin C
Trial: 26213879
Drug: Analgesic administration
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Analgesic administration alone
Trial: 23580740
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of methylphenidate (MPH)
Trial: 17868717
Drug: Brachytherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brachytherapy with a highest dose covering at least 90% of the prostate of 100% or greater
Trial: 11347755
Drug: 5.0 mg
RxNorm normalized name: RUXOLITINIB 5.0 mg ORAL TABLET [JAKAFI]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5.0 mg ramipril
Trial: 3540222
Drug: Instant-release verapamil
RxNorm normalized name: verapamil Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Instant-release verapamil (80 mg tablets, 160 mg twice daily)
Trial: 27417317
Drug: Cabazitaxel (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabazitaxel (20 mg/m² every 3 weeks)
Trial: 27417317
Drug: Cabazitaxel (8.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabazitaxel (8.4 mg/m² weekly)
Trial: 7778548
Drug: Enalapril (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (2.5 to 10 mg twice daily)
Trial: 2389694
Drug: Propranolol (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (40 mg every 6 hours for 6 days)
Trial: 2389694
Drug: Nadolol (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nadolol (80 mg daily for 7 days)
Trial: 30270543
Drug: Dolutegravir (DTG)
DrugBank: Dolutegravir (DB08930)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dolutegravir (DTG) monotherapy
Trial: 18654870
Drug: Undiluted smallpox
RxNorm normalized name: Smallpox vaccine
DrugBank: Smallpox (Vaccinia) Vaccine, Live (DB14711)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Undiluted smallpox vaccine
Trial: 11328240
Drug: Morning bright
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morning bright light therapy (2500 lux)
Trial: 11328240
Drug: Afternoon bright
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Afternoon bright light therapy (2500 lux)
Trial: 7924594
Drug: Combined radiotherapy
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined radiotherapy plus chemotherapy
Trial: 7924594
Drug: Postoperative radiotherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative radiotherapy and chemotherapy
Trial: 7924594
Drug: 5-FU given
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-FU given as continuous infusion
Trial: 11200144
Drug: Preoperative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative treatment
Trial: 3123540
Drug: Cromolyn 20
RxNorm normalized name: cromolyn 20 mg/mL oral solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cromolyn 20 mg
Trial: 6402959
Drug: Cromolyn 40
RxNorm normalized name: cromolyn 40 MG/ACTUAT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cromolyn 40 mg
Trial: 3131405
Drug: Cromolyn 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cromolyn 60 mg
Trial: 25355775
Drug: Root canal
RxNorm normalized name: Canal + Gel 10% for Root Canal Preparation Dental Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Root canal therapy (RCT)
Trial: 7880658
Drug: Colloid (hydroxyethyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colloid (hydroxyethyl starch) 7.5 ml kg‐1
Trial: 7880658
Drug: Crystalloid (lactated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crystalloid (lactated Ringer's) 15 ml kg‐1
Trial: 3284218
Drug: Intravenous diltiazem
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous diltiazem (0.3 mg/kg body weight)
Trial: 29105107
Drug: SPF 70
RxNorm normalized name: Coppertone Kids Sunscreen SPF 70
DrugBank: Homosalate (DB11064)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SPF 70 lotion sunscreen applied at a dosage of 2 mg cm‐2 on half of the face
Trial: 29105107
Drug: SPF 70
RxNorm normalized name: Coppertone Kids Sunscreen SPF 70
DrugBank: Homosalate (DB11064)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SPF 70 spray sunscreen applied at a dosage of 2 mg cm‐2 on one of the forearms
Trial: 20599042
Drug: Idebenone (5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Idebenone (5, 15, and 45 mg/kg, administered orally 3 times a day for 6 months)
Trial: 17142216
Drug: Bedtime insulin
RxNorm normalized name: Buckley's Bedtime Formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bedtime insulin
Trial: 12685385
Drug: Esomeprazole 20
RxNorm normalized name: esomeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 20 mg twice a day for 7 days
Trial: 29507952
Drug: 5-component health
RxNorm normalized name: Perftoran component perfluorodecalin
DrugBank: Perfluorodecalin (DB16292)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-component health care professional HPV vaccine communication intervention
Trial: 22364690
Drug: Torsemide (1/10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Torsemide (1/10 of the daily furosemide dose divided into twice daily dosing)
Trial: 20966667
Drug: Single-shot femoral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-shot femoral nerve block (SSFNB) with concurrent PCA opioids
Trial: 1588374
Drug: High-dose cytarabine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose cytarabine (HIDAC) 3 g/m2 ara-C infused over 3 hours at 12-hour intervals on days 1, 3, and 5
Trial: 1588374
Drug: High-dose cytarabine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose cytarabine (HIDAC)
Trial: 31476786
Drug: Antenatal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antenatal administration of betamethasone
Trial: 31510777
Drug: No carvedilol
RxNorm normalized name: Carvedilol
DrugBank: Carvedilol (DB01136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No carvedilol therapy (control)
Trial: 19746764
Drug: Azelaic acid
RxNorm normalized name: Azelaic Acid
DrugBank: Azelaic acid (DB00548)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Azelaic acid (AzA) gel 15% applied twice daily
Trial: 15491065
Drug: Tamoxifen (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen (10 or 20 mg/day)
Trial: 10762562
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Clarithromycin + Rifabutin)
Trial: 8732472
Drug: Premarin 0.625
RxNorm normalized name: Premarin 0.625mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Premarin 0.625 mg/day
Trial: 27197662
Drug: FEX 60
RxNorm normalized name: Wal-Fex 60 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FEX 60 mg with 300 mL of AJ
Trial: 27197662
Drug: FEX 60
RxNorm normalized name: Wal-Fex 60 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FEX 60 mg with 600 mL of AJ
Trial: 18206190
Drug: Encapsulated L-phenylalanine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Encapsulated L-phenylalanine (Phe) in the luteal phase for women in the higher 50th percentile of rigid restraint
Trial: 18206190
Drug: Encapsulated L-phenylalanine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Encapsulated L-phenylalanine (Phe)
Trial: 8866639
Drug: Intracavernous injection
RxNorm normalized name: Bivalirudin 250 mg INTRACAVERNOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracavernous injection of moxisylyte at 10 mg
Trial: 8866639
Drug: Intracavernous injection
RxNorm normalized name: Bivalirudin 250 mg INTRACAVERNOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracavernous injection of moxisylyte at 30 mg
Trial: 15737519
Drug: Telithromycin 800
RxNorm normalized name: Telithromycin
DrugBank: Telithromycin (DB00976)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telithromycin 800 mg for 5 days
Trial: 9469269
Drug: Azithromycin, 1
RxNorm normalized name: Azithromycin, 1 g oral powder for reconstitution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin, 1 g oral slurry in a single dose
Trial: 9469269
Drug: Erythromycin, 500
RxNorm normalized name: Erythromycin, 500 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin, 500 mg every 6 hours for 7 days
Trial: 31005336
Drug: BI 425809
RxNorm normalized name: BI 2536
DrugBank: BI 2536 (DB16107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BI 425809 (10, 25, or 50 mg)
Trial: 29091568
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ACE inhibitor and statin
Trial: 23806287
Drug: Ambulatory oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ambulatory oxygen at 4 L/min intranasally
Trial: 23806287
Drug: Ambulatory air
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ambulatory air at 4 L/min intranasally
Trial: 11763936
Drug: Colgate Winterfresh
RxNorm normalized name: Colgate
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Colgate Winterfresh Gel (1100 ppm F)
Trial: 9001831
Drug: Cimetidine 800
RxNorm normalized name: cimetidine 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 800 mg BID
Trial: 8111819
Drug: Cimetidine 400
RxNorm normalized name: cimetidine 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 400 mg QID
Trial: 24808487
Drug: Lutein supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lutein supplement meal
Trial: 24808487
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 29 SNPs in 15 genes
Trial: 15790459
Drug: Paclitaxel 200
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 200 mg/m² IV infusion on day 1, Carboplatin AUC 6.0 IV on day 1, Etoposide 50 mg alternating with 100 mg orally on days 1-10, 6 courses at 21-day intervals
Trial: 10498115
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C supplementation at a dosage of 500 to 1,000 mg per day
Trial: 7585298
Drug: Liquid supplement
RxNorm normalized name: Clear liquid supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liquid supplement containing fat (30 to 36 g) and cholesterol (650 to 780 mg)
Trial: 7585298
Drug: Liquid supplement
RxNorm normalized name: Clear liquid supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liquid supplement that was fat and cholesterol free
Trial: 6263091
Drug: Lithium (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lithium (300 mg three times daily for 18 days of every 21 day chemotherapy cycle)
Trial: 24917273
Drug: Methotrexate (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methotrexate (25 mg weekly)
Trial: 22555266
Drug: Cardiac resynchronization
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiac resynchronization therapy (CRT) in NYHA functional class III/IV
Trial: 18846541
Drug: Amantadine (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amantadine (400 mg/day)
Trial: 11840184
Drug: Tamarind (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamarind (10 g daily for 18 days)
Trial: 30951624
Drug: Prosthetic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prosthetic treatment of missing teeth
Trial: 30951624
Drug: Professional periodontal
RxNorm normalized name: Clearskin Professional Daily Correcting
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Professional periodontal treatment
Trial: 1805808
Drug: Sun E45
RxNorm normalized name: CLOZAPINE (SUN)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sun E45 lotion SPF 15
Trial: 31047857
Drug: Multidomain lifestyle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidomain lifestyle intervention (cognitive training, physical activity counseling, nutritional counseling) with omega-3 supplement for 3 years
Trial: 22266897
Drug: Bupivacaine extended-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine extended-release (150, 300, 450, or 600 mg)
Trial: 22266897
Drug: Bupivacaine HCl
RxNorm normalized name: bupivacaine HCl
DrugBank: Bupivacaine (DB00297)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bupivacaine HCl 150 mg with epinephrine
Trial: 22266897
Drug: Bupivacaine extended-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine extended-release
Trial: 9342068
Drug: Liposomal amphotericin
RxNorm normalized name: Liposomal amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liposomal amphotericin B (AmBisome) 4 mg/kg daily for 3 weeks followed by fluconazole 400 mg daily for 7 weeks
Trial: 30692242
Drug: Hybrid closed-loop
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hybrid closed-loop with standard strength insulin (U100)
Trial: 30692242
Drug: Hybrid closed-loop
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hybrid closed-loop with diluted insulin (U20)
Trial: 25499006
Drug: DCLHb (diasiirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DCLHb (diasiirin cross-linked hemoglobin) as add-on therapy
Trial: 23453111
Drug: Granulocyte colony-stimulating
RxNorm normalized name: Granulocyte colony-stimulating factor lenograstim
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte colony-stimulating factor (G-CSF) 300 μg daily subcutaneous injection for 5 days
Trial: 9743952
Drug: High-dose methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methotrexate (HD-MTX) with reduced CRT (12 Gy for IR, 18 Gy for MR, and 18 Gy for HR)
Trial: 9743952
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of CRT (12 Gy) and HD-MTX in T-cell ALL patients